Corebridge Financial’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,212
| Closed | -$165K | – | 1466 |
|
|
2025
Q1 | $165K | Buy |
16,212
+972
| +6% | +$9.91K | ﹤0.01% | 2179 |
|
|
2024
Q4 | $241K | Sell |
15,240
-515
| -3% | -$8.15K | ﹤0.01% | 2072 |
|
|
2024
Q3 | $915K | Sell |
15,755
-97
| -0.6% | -$5.63K | ﹤0.01% | 1401 |
|
|
2024
Q2 | $724K | Buy |
+15,852
| New | +$724K | ﹤0.01% | 1501 |
|